What does parexel do?
PAREXEL International Corporation is a global biopharmaceutical services The Company provides contract research, consulting, medical communications, and technology solutions. The Company provides its services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Is parexel a CRO?
Parexel is in the business of improving the world’s health. As a leading CRO, we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.
What industry is parexel?
biopharmaceutical services
Parexel International is an American provider of biopharmaceutical services….Parexel.
| Type | Private |
|---|---|
| Industry | Clinical research organizations Pharmaceutical |
| Founded | 1982 |
| Headquarters | Durham, North Carolina, U.S. Newton, Massachusetts, U.S. |
Is parexel publicly traded?
The deal comes four years after Parexel was purchased by Pamplona Capital Management for about $5.5 billion, taking the then publicly traded CRO private.
Who is the owner of Parexel?
EQT IX Fund
Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion. Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
Is parexel a good company to work for?
Is Parexel a good company to work for? Parexel has an overall rating of 3.7 out of 5, based on over 2,488 reviews left anonymously by employees. 68% of employees would recommend working at Parexel to a friend and 61% have a positive outlook for the business.
Who bought parexel?
North Carolina-based clinical research organization (CRO) Parexel has announced the execution of a definitive merger agreement, under which the company will be purchased by EQT Private Equity and Goldman Sachs for $8.5b USD.
Is Parexel a good company?
Is Parexel a good company to work for? Parexel has an overall rating of 3.7 out of 5, based on over 2,488 reviews left anonymously by employees. 68% of employees would recommend working at Parexel to a friend and 61% have a positive outlook for the business. This rating has improved by 1% over the last 12 months.
Is Parexel a Fortune 500 company?
Figures are for fiscal year ended June 30, 2016….Company Info.
| CEO | Josef H. von Rickenbach |
|---|---|
| Website | http://www.parexel.com |
| Years on Fortune 500 List | – |
| Employees | 18,600 |
Who is buying Parexel?
EQT
(Reuters) -Goldman Sachs Group Inc’s investment arm and Swedish private equity firm EQT AB said on Friday they will buy clinical research company Parexel International Corp from Pamplona Capital Management for $8.5 billion.
Who is Parexel owned by?
Who is PAREXEL?
Parexel is in the business of improving the world’s health. As a leading CRO, we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.
Why choose Parexel biotech?
Get the Parexel Biotech perspective on maximizing the chances of success and addressing some of the most significant challenges in rare disease drug development. The future of clinical trials is now, and we’re committed to creating innovations that make this research accessible to more people.
Why choose pparexel?
Parexel is in the business of improving the world’s health. As a leading CRO, we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. The future is now! We deliver DCTs with patients at the heart of our approach.